Back to News
Market Impact: 0.2
Kaplan Fox Reminds Investors of a Securities Class Action Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) – Deadline is September 28, 2026
Source: globenewswire.com
Legal & LitigationCompany Fundamentals
Kaplan Fox & Kilsheimer LLP announced a class action lawsuit has been filed against Capricor Therapeutics (NASDAQ: CAPR) on behalf of investors. The news is a negative legal overhang and could pressure sentiment around CAPR, though no financial impact or allegations are detailed in the excerpt.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
CAPR-0.90
More News
- ‘If nothing is done, it’s almost inevitable’: Ukraine’s Yuriy Ryzhenkov on why steelmaking is on the brink of collapse as Russian bombing intensifies
- Why is LG Innotek stock plunging today?
- TotalEnergies, KKR expand U.S. solar venture with 700 MW addition
- Senior Iranian official threatens to attack cables, data centers, and AI facilities in the region if the war escalates sharply again
- Vår Energi cuts 2026 output forecast; Q3 production at 369,000 boepd
- TSMC expected to report sixth straight quarter of record profit thanks to AI boom